Market Overview

Premarket Approval Doc For Balloon System Sends Obalon Shares Sharply Higher


Obalon Therapeutics (NASDAQ: OBLN) shares spiked about 30 percent following circulation of a Food and Drug Administration document for the weight loss Obalon balloon system.

The Obalon Balloon System is a swallowable intragastric balloon system indicated for temporary use to facilitate weight loss in adults with obesity.

Obalon Therapeutics traded at $1.47 per share at time of publication, up 12 percent.

Related Link:

Obalon Closes Above $1 Following Questionable Takeover Rumor


Related Articles (OBLN)

View Comments and Join the Discussion!

Posted-In: News FDA Movers Trading Ideas